Intensity Therapeutics, Inc Common stock

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$24
$0
Gross Profit
-7
-6
12
-7
EBITDA
-2,705
-3,394
-3,175
-3,513
EBIT
-3,400
-3,181
-3,520
Net Income
-2,537
-3,347
-3,181
-3,513
Net Change In Cash
0
0
24
0
Free Cash Flow
-2,456
-1,989
-2,668
-3,972
Cash
2,216
929
2,590
2,782
Basic Shares
18,868
15,173
14,628
13,804

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-25
-147
-179
EBITDA
-16,243
-10,086
-7,402
-8,013
EBIT
-16,268
-10,233
-7,581
-8,013
Net Income
-16,268
-10,538
-7,451
-7,892
Net Change In Cash
0
0
0
0
Free Cash Flow
-15,220
-7,205
-5,477
-6,826
Cash
2,590
8,556
1,311
4,539
Basic Shares
13,906
8,616
13,099
13,099

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.13
2025-03-31
-$0.22
2024-12-31
-$1.17